Author:
Lenzhofer R.,Ganzinger U.,Rameis H.,Moser K.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference25 articles.
1. Bristow MR, Mason JW, Billingham ME, Daniels JR (1981) Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J 102:709?718
2. Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL Blumenschein GR, Freireich EJ (1982) Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96:133?139
3. B�hner R, Biedert S, Miura D (1980) Erh�hung des frei-ionisierten zytoplasmatischen Calciums als Ursache der Adriamycin-Kardiomyopathie. Klin Wochenschr 58:747?748
4. Chan KK, Cohen JL, Gross JF, Himmelstein KJ, Bateman, JR, Tsu-Lee Y, Marlis AS (1978) Predicition of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat Rep 62:1161?1171
5. Di Fronzo G, Bertuzzi A, Ronchi E, Villani FP, Ronchetti L (1979) Evaluation of cardiac activity and pharmacokinetic analysis of 3H-adriamycin in patients pretreated with beta-methyldigoxin. Cancer Chemother Pharmacol 2:169?173
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献